Journal
EMBO JOURNAL
Volume 35, Issue 3, Pages 335-355Publisher
WILEY
DOI: 10.15252/embj.201593235
Keywords
alternative splicing; CTCF; DNA methylation; TET1; TET2
Categories
Funding
- Intramural Research Program of NIH
- National Cancer Institute
- Center for Cancer Research
Ask authors/readers for more resources
Intragenic 5-methylcytosine and CTCF mediate opposing effects on pre-mRNA splicing: CTCF promotes inclusion of weak upstream exons through RNA polymerase II pausing, whereas 5-methylcytosine evicts CTCF, leading to exon exclusion. However, the mechanisms governing dynamic DNA methylation at CTCF-binding sites were unclear. Here, we reveal the methylcytosine dioxygenases TET1 and TET2 as active regulators of CTCF-mediated alternative splicing through conversion of 5-methylcytosine to its oxidation derivatives. 5-hydroxymethylcytosine and 5-carboxylcytosine are enriched at an intragenic CTCF-binding sites in the CD45 model gene and are associated with alternative exon inclusion. Reduced TET levels culminate in increased 5-methylcytosine, resulting in CTCF eviction and exon exclusion. In vitro analyses establish the oxidation derivatives are not sufficient to stimulate splicing, but efficiently promote CTCF association. We further show genomewide that reciprocal exchange of 5-hydroxymethylcytosine and 5-methylcytosineat downstream CTCF-binding sites is a general feature of alternative splicing in naive and activated CD4(+) T cells. These findings significantly expand our current concept of the pre-mRNA splicing code to include dynamic intragenic DNA methylation catalyzed by the TET proteins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available